本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nuvation Bio, Inc.

4.90
-0.1000-2.00%
盘后:4.990.0900+1.84%19:57 EDT
成交量:318.30万
成交额:1,563.46万
市值:17.21亿
市盈率:-11.17
高:5.01
开:4.96
低:4.88
收:5.00
52周最高:9.75
52周最低:3.36
股本:3.51亿
流通股本:2.64亿
量比:0.46
换手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-0.4387
每股收益(LYR):-0.6000
净资产收益率:-47.81%
总资产收益率:-12.36%
市净率:6.78
市盈率(LYR):-8.17

数据加载中...

2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/06

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/26

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/10

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/12

重要事件披露

Form 8-K - Current report